Doctors in Tayside are working on ‘Realistic Medicine’ – a set of challenges set by the Chief Medical Officer for Scotland, Catherine Calderwood. These address the complex health and social care challenges faced by those in today’s society.
‘My Diabetes My Way’ has been developed in Dundee to provide a new support and learning platform for those living with diabetes in Scotland.
A £25m investment to grow the Tayside Biomedical Cluster will allow the region to become one of the most attractive biomedical locations in the UK as well as fostering innovation in the field.
Surgical robots, virtual reality headsets and interactive anatomy stations are among the hi-tech innovations that feature in a centre spearheaded by the University of Dundee, NHS Tayside and industry partners Medtronic.
Doctors from around the world have been among those taking advantage of the ground-breaking training opportunities on offer at DIHS, the first single-site facility in Scotland offering both surgical and clinical training.
The University of Dundee was named the world’s most influential pharmaceuticals research institution in a major global survey. ‘The State of Innovation’ report by Clarivate Analytics ranked Dundee as the most influential scientific research institution in pharmaceuticals for 2006-16.
Research at Dundee has a significant impact on research into therapeutic areas including cancer, arthritis, diabetes, lupus, hypertension and Parkinson’s disease. The University’s Drug Discovery Unit collaborates with partners to translate world-class biology research into novel drug targets and candidate drugs across multiple disease areas.
Joint research by The University of St Andrews and the University of Edinburgh have identified a specific type of cell in the human body which can cause motor neurons to fail using stem cell technology. This is new information which highlights targets for the development of treatments, and ultimately a cure, for Motor Neuron Disease.